Clinical Trials Browser

Phase 3 × Lung Neoplasms × RRx-001 × Clear all

NCT03699956 2024-03-26

REPLATINUM

Phase 3 Terminated

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma